The Uromigos Episode 59: Ipatercertib in Biomarker Positive Castrate Resistant Prostate Cancer

By The Uromigos - September 20, 2020

Chris Sweeney (last author) discusses the ATK inhibitor Ipatercertib in pTEN altered castrate resistant prostate cancer. A positive R3 trial in the ESMO plenary session.

Post Tags:Uromigos-ESMOUromigos-Prostate Cancer
Did you like this article?